WASP Classification in Diagnosis of Diminutive Colorectal Polyps

NCT03903497 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2640

Last updated 2022-05-18

No results posted yet for this study

Summary

Adenomas, serrated adenomas and hyperplastic polyps are polypoid lesion in the colorectum. At the present moment, all polyps should be resected endoscopically, although only adenomas and serrated adenomas, but not hyperplastic polyps have the potential to develop colorectal cancer. Some studies have investigated the value of the narrow-band imaging (NBI) on histological prediction of the polyp. This method is conducted in real time during colonoscopy, which leads to simplification of diagnostic procedures. For instance, it would be conceivable to resect diminutive polyps and discard them without further assessment by a pathologist. One problem in this context is a correct differentiation between hyperplastic polyps and serrated adenomas. These two polyp entities are known to show similar optical features. However, while serrated adenomas are premalignant lesions hyperplastic polyps have benign histology and never develop into cancer. It is therefore important to sufficiently distinguish hyperplastic polyps from serrated lesions.

In this study the investigators want to investigate whether the use of NBI would be capable to get accuracy of optical polyp predictions by more than 90% using the WASP (Workgroup serrAted polypS and Polyposis) classification. NBI is a light filter tool which can be activated by pressing a button at the endoscope. The use of NBI leads to an endoscopic picture which appears blue and enables endoscopists to better assess surface structures and vascular patterns. All polyps will be resected and send to pathology for further microscopic assessment. After completing the trial the investigators aim to compare accuracy of the optical diagnosis.

Conditions

  • Diminutive Colorectal Polyps

Interventions

DEVICE

NBI

optical assessment of diminutive colorectal polyps by NBI mode using the WASP assessment

Sponsors & Collaborators

  • Beijing Friendship Hospital

    collaborator OTHER
  • Jilin People's Hospital

    collaborator UNKNOWN
  • Wafangdian Third Hospital

    collaborator UNKNOWN
  • Dezhou People's Hospital

    collaborator OTHER
  • Liaocheng People's Hospital

    collaborator OTHER
  • Wenzhou Central Hospital

    collaborator OTHER
  • Yichun People's Hospital

    collaborator UNKNOWN
  • The Third Xiangya Hospital of Central South University

    collaborator OTHER
  • Shenzhen Baoan People's Hospital

    collaborator UNKNOWN
  • Xinxiang Central Hospital

    collaborator OTHER
  • Wuwei Cancer Hospital

    collaborator UNKNOWN
  • Zunyi Medical College

    collaborator OTHER
  • Yaan People's Hospital

    collaborator UNKNOWN
  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2022-12-30
Completion
2023-05-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03903497 on ClinicalTrials.gov